T2 Biosystems (TTOO) Scheduled to Post Earnings on Tuesday
T2 Biosystems (NASDAQ:TTOO) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, November 12th. Analysts expect T2 Biosystems to post earnings of ($0.31) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.
Shares of T2 Biosystems stock opened at $2.66 on Monday. T2 Biosystems has a one year low of $0.52 and a one year high of $5.38. The company has a market cap of $128.71 million, a price-to-earnings ratio of -2.11 and a beta of 1.23. The business’s 50 day moving average price is $2.58 and its 200 day moving average price is $1.97.
A number of equities analysts recently commented on the company. Janney Montgomery Scott upgraded T2 Biosystems from a “neutral” rating to a “buy” rating and set a $6.00 price objective on the stock in a research report on Thursday, September 12th. HC Wainwright reiterated a “hold” rating on shares of T2 Biosystems in a research report on Wednesday, August 7th. Zacks Investment Research upgraded T2 Biosystems from a “sell” rating to a “hold” rating in a research report on Friday, October 25th. Leerink Swann set a $5.00 target price on T2 Biosystems and gave the company a “buy” rating in a research report on Thursday, September 12th. Finally, ValuEngine upgraded T2 Biosystems from a “sell” rating to a “hold” rating in a research report on Thursday, August 1st. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $5.18.
T2 Biosystems, Inc, an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine.
See Also: Roth IRA
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.